|The remaining capacity:||0|
|Time:||Tuesday (16th November 2021)- 19-20 (Tehran Time)|
TUMS Preclinical Core Facility (TPCF) presents:
International Webinar entitled:
Department of Biochemistry, Microbiology and Immunology at the University of Ottawa
director of the Molecular Imaging Probes and Radiochemistry Laboratory at the University of Ottawa Heart Institute
Molecular imaging of dynamic biochemical processes is used to study normal and diseased conditions, evaluate response to therapy, and for clinical diagnosis. Radiotracers for positron emission tomography (PET) or single-photon emission computed tomography (SPECT) contain short-lived radioactive isotopes and engage in highly specific and selective molecular interactions with enzyme or receptor targets in vivo. Radiotracer development therefore demands a confluence of understanding of biochemical processes and targets, medicinal chemistry and probe design, synthetic and radiochemistry, as well as pharmacology and imaging analysis. From a foundation in all aspects of radiopharmaceutical chemistry, our laboratory seeks to develop strategies and methods for application ultimately in nuclear molecular imaging research and clinical diagnosis.